SIRCE II
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The U.S. Food and Drug Administration (FDA) is conducting market research through a Request for Information (RFI) for the Systems for Inspection & Imports, Recalls Compliance, and Enforcement (SIRCE) II initiative. This RFI seeks qualified vendors capable of providing comprehensive IT modernization and support services for a potential 5-year, up to $400M effort. The FDA is particularly interested in industry capabilities related to large-scale IT modernization, hybrid cloud environments, Artificial Intelligence (AI)/Machine Learning (ML), DevSecOps, and rapid scaling. Responses are due by March 6, 2026, 12 PM ET.
Purpose
This RFI is issued solely for market research purposes to assess industry capabilities, capacity, and innovative approaches for delivering IT modernization and support services for the FDA's Office of Information and Innovation (OII) systems. It aims to gather feedback on the solicitation approach, evaluation criteria, technical requirements, pricing, and innovation opportunities.
Scope of Work
The SIRCE II effort encompasses Systems Integration and Engineering Services, Architecture Support Services, and extensive Artificial Intelligence (AI) Services. Key areas include:
- Systems Integration & Engineering: Developing integration and interoperability strategies, phasing out legacy systems, and recommending solutions for business/mission needs.
- Architecture Support: Providing full-range architecture support to minimize costs, support intuitive workflows, and develop software using modern design principles.
- Artificial Intelligence (AI) Services: Comprehensive AI adoption and implementation, enhancing existing systems with AI capabilities, developing standalone AI-driven solutions, and supporting the full spectrum of AI technologies (e.g., machine learning, generative AI). Representative AI tasks include strategy, planning, solution development, and integration for areas like risk scoring, NLP, computer vision, predictive analytics, and intelligent automation. Ethical practices and FDA compliance are critical for AI development.
- Key Requirements: Implementing modern technology, retiring legacy systems, automated provisioning/deployments, minimizing failure rates, right-sizing system resources, managing hybrid cloud environments, meeting security standards, rapid onboarding of team members, and maintaining Operations and Maintenance (O&M) procedures.
Technology Stack
The representative technology stack includes a diverse range of platforms and tools:
- Infrastructure: On-premise, AWS EC2, Azure, Google Cloud Platforms, Oracle HTTP Server, Oracle Linux, RedHat Linux, Windows.
- Software Development: Agile, DevSecOps, Jenkins, Git/GitLab, Docker, Kubernetes.
- Artificial Intelligence: Amazon SageMaker, Bedrock, Azure AI, Google Vertex AI, frontier models, MLOps, RAG, MCP, A2A, customizable LLMs.
- Data: Databricks on AWS, MS SQL, Oracle, PostgreSQL, MariaDB, AWS S3, SQLite.
- Monitoring & Testing: AWS CloudWatch, Grafana, SolarWinds, Selenium, Katalon Studio, Appium, JMeter, AMP, NVDA.
- Other: Java, J2EE, .NET, Python, AngularJS, REST/JSON, SOAP.
Contract & Timeline
- Type: Sources Sought (Request for Information)
- Anticipated Contract: Five (5) year period of performance, estimated value up to $400M.
- Task Orders: Anticipated 2-4 per year, with awardees having fifteen (15) business days to respond and staff.
- Set-Aside: None specified.
- Response Due: March 6, 2026, 12 PM Eastern Time.
- Published: February 19, 2026.
- Place of Performance: Rockville, MD, United States.
Submission & Contact
Interested companies must submit a Capability Statement (limited to five (5) pages) via email to Noah.Padilla@fda.hhs.gov. This RFI is for market research only and does not constitute a solicitation for proposals.